Chalcone hybrids as potential anticancer agents: Current development, mechanism of action, and structure-activity relationship.

Medicinal Research Reviews
Feng GaoJiaqi Xiao

Abstract

The continuous emergency of drug-resistant cancers and the low specificity of anticancer agents have been the major challenges in the control and treatment of cancer, making an urgent need to develop novel anticancer agents with high efficacy. Chalcones, precursors of flavonoids and isoflavonoids, exhibit structural heterogeneity and can act on various drug targets. Chalcones which demonstrated potential in vitro and in vivo activity against both drug-susceptible and drug-resistant cancers, are useful templates for the development of novel anticancer agents. Hybridization of chalcone moiety with other anticancer pharmacophores could provide the hybrids which have the potential to overcome drug resistance and improve the specificity, so it represents a promising strategy to develop novel anticancer agents. This review emphasizes the development, the mechanisms of action as well as structure-activity relationships of chalcone hybrids with potential therapeutic application for many cancers in recent 10 years.

References

May 17, 2005·Mini Reviews in Medicinal Chemistry·C Asche
Aug 2, 2007·Accounts of Chemical Research·Bernard Meunier
Dec 17, 2009·Bioorganic & Medicinal Chemistry·Yali KongMilton L Brown
Jul 16, 2010·Bioorganic & Medicinal Chemistry Letters·Dalip KumarTakeo Ito
Jul 20, 2010·Bioorganic & Medicinal Chemistry Letters·Ahmed KamalManika Pal-Bhadra
Jul 20, 2010·Bioorganic & Medicinal Chemistry·Mauricio CabreraMercedes González
Aug 31, 2010·Bioorganic & Medicinal Chemistry Letters·Sergio ValenteGilbert Kirsch
Nov 13, 2010·Bioorganic & Medicinal Chemistry Letters·Koneni V SashidharaSudhir Sinha
Apr 27, 2011·Cancer Cell International·M Janaki RamaiahManika Pal Bhadra
Aug 2, 2011·Chemical & Pharmaceutical Bulletin·Lijun XieYanfang Zhao
Oct 11, 2011·Archiv der Pharmazie·Lijun XiePing Gong
Mar 24, 2012·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·V Raja Solomon, Hoyun Lee
Jun 19, 2012·European Journal of Medicinal Chemistry·Mai A E MouradHassan H Farag
Sep 19, 2012·Cell Biochemistry and Function·Alana de VasconcelosAlethéa Gatto Barschak
Oct 10, 2012·European Journal of Medicinal Chemistry·Rodrigo AboniaJusto Cobo
Nov 20, 2012·Future Medicinal Chemistry·Shivaputra A PatilDuane D Miller
Dec 25, 2012·Archives of Pharmacal Research·Loghman FiroozpourAlireza Foroumadi
Dec 30, 2010·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Chuanfei JinLiwu Fu
Mar 23, 2013·Archiv der Pharmazie·Xianwen FangJia Zhou
Apr 16, 2013·European Journal of Medicinal Chemistry·Rajesh A RanePavankumar Bangalore
Apr 24, 2013·Bioorganic & Medicinal Chemistry Letters·Seok-Ho KimYounghwa Na
May 9, 2013·ChemMedChem·Paula LorenzoAngel R de Lera
Jul 31, 2013·Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association·Han WeiJinlan Ruan
Dec 18, 2013·Bioorganic & Medicinal Chemistry Letters·Branka KolundžijaMilan D Joksović
Mar 8, 2014·European Journal of Medicinal Chemistry·Mohamed Ramadan El Sayed AlySherif Yousef Saleh
Mar 19, 2014·Apoptosis : an International Journal on Programmed Cell Death·Neetu SinghSudhir Sinha
Apr 22, 2014·Bioorganic Chemistry·Maosheng WanPeifu Jiao
May 23, 2014·Bioorganic & Medicinal Chemistry Letters·Shikha S ChauhanPrem M S Chauhan
Jul 12, 2014·Chemical Research in Toxicology·Darja GramecMarija Sollner Dolenc
Aug 1, 2014·European Journal of Medicinal Chemistry·Ratchanok PingaewVirapong Prachayasittikul
Aug 21, 2014·Recent Patents on Anti-cancer Drug Discovery·Chandrabose KarthikeyanPiyush Trivedi
Oct 18, 2014·Anti-cancer Agents in Medicinal Chemistry·Magda F MohamedIsmail Abdelshafy Abdelhamid
Dec 3, 2014·Bioorganic & Medicinal Chemistry Letters·Dalip KumarTakeo Ito
Dec 3, 2014·European Journal of Medicinal Chemistry·Frans J SmitDavid D N'Da

❮ Previous
Next ❯

Citations

Jul 3, 2021·Biomolecules·Yang OuyangQi Wu
Aug 1, 2021·European Journal of Medicinal Chemistry·Bo Luo, Xinqiang Song
Aug 28, 2021·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Yong-Feng GuanSai-Yang Zhang
Sep 10, 2020·Current Topics in Medicinal Chemistry·Feng SongMeng Zhou
Oct 24, 2020·Current Topics in Medicinal Chemistry·Jiaqi XiaoFeng Gao

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.